All Work

Chris Lange

Lululemon Stretches Earnings in Q2

Lululemon released better than expected fiscal second-quarter financial results after the markets closed on Thursday.

Chris Lange · 7 years ago

Why This Analyst Sees Cidara Nearly Doubling

While just announced huge deal seems to be the big break that Cidara Therapeutics needs, one analyst believes this stock could nearly double in the next 12 months.

Chris Lange · 7 years ago

Signet Jewelers Shines in Q2

Signet Jewelers released better than expected fiscal second-quarter financial results before the markets opened on Thursday.

Chris Lange · 7 years ago

Palo Alto Networks Slips Up in Q4

Palo Alto Networks reported better than expected fiscal fourth-quarter financial results after the markets closed on Wednesday.

Chris Lange · 7 years ago

After-Hours Moves in Rising Tech Firms

A handful of tech companies have reported after the closing bell and a few of these firms made big moves. 24/7 Wall St. has taken a look at these earnings reports and broken down…

Chris Lange · 7 years ago

Alphabet Shrugs Off Record FTC Fine

Alphabet has been under a tremendous amount of scrutiny of late, and part of this is coming to a head. The FTC has levied a $170 million fine against its subsidiary YouTube for violating…

Chris Lange · 7 years ago

Is Starbucks in Trouble Going Forward?

Starbucks shares dipped slightly on Wednesday after the coffee chain announced at the Goldman Sachs Global Retailer Conference that its 2020 growth outlook may not be up to snuff.

Chris Lange · 7 years ago

Here’s the Big Break for Cidara’s Fungal Infection Study

Cidara Therapeutics shares saw a massive gain on Tuesday after the firm announced that it has entered into a strategic partnership with Mundipharma to develop and commercialize Cidara’s treatment for invasive fungal infections.

Chris Lange · 7 years ago